Sabra Competitors
| SBRA Stock | USD 20.03 0.56 2.72% |
Sabra Healthcare vs Howard Hughes Correlation
Average diversification
The correlation between Sabra Healthcare REIT and HHH is 0.13 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Sabra Healthcare REIT and HHH in the same portfolio, assuming nothing else is changed.
Moving against Sabra Stock
As of February 19, 2026, Return On Tangible Assets is expected to decline to 0.02. In addition to that, Return On Capital Employed is expected to decline to 0.04. At present, Sabra Healthcare's Other Assets are projected to increase significantly based on the last few years of reporting. The current year's Total Current Assets is expected to grow to about 332.1 M, whereas Total Assets are forecasted to decline to about 4.4 B.Sabra Healthcare Competition Correlation Matrix
Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Sabra Healthcare and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Sabra and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Sabra Healthcare REIT does not affect the price movement of the other competitor.
High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Sabra Stock performing well and Sabra Healthcare Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Sabra Healthcare's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| NHI | 0.95 | 0.27 | 0.17 | (0.66) | 1.00 | 2.16 | 5.29 | |||
| ABR | 1.86 | (0.31) | 0.00 | (0.22) | 0.00 | 3.59 | 10.47 | |||
| PECO | 0.75 | 0.16 | 0.17 | (1.62) | 0.49 | 1.81 | 4.30 | |||
| EPR | 0.90 | 0.20 | 0.14 | (14.29) | 0.90 | 2.02 | 5.27 | |||
| MAC | 1.38 | 0.08 | 0.03 | 0.24 | 1.91 | 2.66 | 9.82 | |||
| CUZ | 1.33 | (0.14) | 0.00 | (0.13) | 0.00 | 3.02 | 11.95 | |||
| MRP | 1.38 | (0.01) | (0.01) | 0.02 | 1.61 | 3.67 | 7.64 | |||
| SLG | 1.81 | (0.39) | 0.00 | (0.23) | 0.00 | 3.11 | 9.07 | |||
| PSA | 1.17 | 0.11 | 0.08 | 0.16 | 1.16 | 2.84 | 6.57 | |||
| HHH | 1.24 | (0.12) | 0.00 | (0.08) | 0.00 | 2.69 | 10.35 |
Cross Equities Net Income Analysis
Compare Sabra Healthcare REIT and related stocks such as National Health Investors, Arbor Realty Trust, and Phillips Edison Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NHI | 2.1 M | 81.1 M | 90.7 M | 106.2 M | 101.6 M | 148.9 M | 151.5 M | 159.4 M | 154.3 M | 160.5 M | 185.1 M | 111.8 M | 66.4 M | 135.7 M | 138 M | 158.7 M | 89.3 M |
| ABR | 3.4 M | (40.3 M) | 16.2 M | 21.2 M | 93 M | 53.4 M | 50.4 M | 73.4 M | 115.9 M | 128.6 M | 170.9 M | 339.3 M | 325.8 M | 371.4 M | 264.6 M | 304.3 M | 319.6 M |
| PECO | (2.4 M) | (2.4 M) | (3.3 M) | (12.4 M) | (22.6 M) | 13.4 M | 8.9 M | (38.4 M) | 39.1 M | (63.5 M) | 4.8 M | 15.1 M | 48.3 M | 56.8 M | 62.7 M | 111.3 M | 116.9 M |
| EPR | 1.4 M | 115.2 M | 121.6 M | 180.2 M | 179.6 M | 194.5 M | 225 M | 263 M | 267 M | 154.6 M | (131.7 M) | 98.6 M | 176.2 M | 173 M | 146.1 M | 168 M | 113.4 M |
| MAC | 8.6 M | 156.9 M | 337.4 M | 420.1 M | 1.5 B | 486.1 M | 517 M | 145.4 M | 60 M | 96.8 M | (230.2 M) | 14.3 M | (66.1 M) | (274.1 M) | (194.1 M) | (197.1 M) | (187.3 M) |
| CUZ | 9.4 M | (128.4 M) | 45.7 M | 121.8 M | 52 M | 125.5 M | 79.1 M | 216.3 M | 79.2 M | 101.6 M | 237.3 M | 278.6 M | 166.8 M | 83 M | 46 M | 40.5 M | 38.5 M |
| MRP | (144.3 M) | (144.3 M) | (144.3 M) | (144.3 M) | (144.3 M) | (144.3 M) | (144.3 M) | (144.3 M) | (144.3 M) | (144.3 M) | (144.3 M) | (144.3 M) | (144.3 M) | (209.8 M) | (246.2 M) | (221.6 M) | (232.7 M) |
| SLG | 27.2 M | 601.3 M | 117.1 M | 137.6 M | 520.8 M | 291.1 M | 261.1 M | 112.8 M | 258.6 M | 281.3 M | 379.8 M | 457.1 M | (71.6 M) | (543.5 M) | 30.7 M | (88.3 M) | (83.9 M) |
| PSA | 2.8 M | 823.8 M | 939.3 M | 1.1 B | 1.1 B | 1.3 B | 1.5 B | 1.4 B | 1.7 B | 1.5 B | 1.4 B | 2 B | 4.3 B | 2.1 B | 2.1 B | 1.8 B | 1.9 B |
Sabra Healthcare REIT and related stocks such as National Health Investors, Arbor Realty Trust, and Phillips Edison Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Sabra Healthcare REIT financial statement analysis. It represents the amount of money remaining after all of Sabra Healthcare REIT operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Sabra Healthcare Competitive Analysis
The better you understand Sabra Healthcare competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Sabra Healthcare's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Sabra Healthcare's competition over several years is one of the best ways to analyze its investment potential.| Better Than Average | Worse Than Peers | View Performance Chart |
Sabra Healthcare Competition Performance Charts
Five steps to successful analysis of Sabra Healthcare Competition
Sabra Healthcare's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Sabra Healthcare REIT in relation to its competition. Sabra Healthcare's competition analysis typically involves several steps, including:- Identifying the key players in the market: This involves identifying the major competitors of Sabra Healthcare in the market, both direct and indirect, as well as new entrants and disruptive technologies.
- Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
- Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Sabra Healthcare's competitive landscape.
- Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Sabra Healthcare REIT, and developing a strategy to address them.
- Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Complement your Sabra Healthcare position
In addition to having Sabra Healthcare in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Small Growth Funds Thematic Idea Now
Small Growth Funds
Funds or Etfs that invest in stocks of small to mid-sized companies with above-average risk and growth rate that usually reinvest their earnings back into business. The Small Growth Funds theme has 42 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Small Growth Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Sabra Healthcare Correlation with its peers. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Is Diversified REITs space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sabra Healthcare. If investors know Sabra will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Sabra Healthcare assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Quarterly Earnings Growth (0.45) | Dividend Share 1.2 | Earnings Share 0.62 | Revenue Per Share | Quarterly Revenue Growth 0.158 |
Understanding Sabra Healthcare REIT requires distinguishing between market price and book value, where the latter reflects Sabra's accounting equity. The concept of intrinsic value - what Sabra Healthcare's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Sabra Healthcare's price substantially above or below its fundamental value.
Please note, there is a significant difference between Sabra Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sabra Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Sabra Healthcare's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.